{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:12:30Z","timestamp":1785795150821,"version":"3.56.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/14183-7"],"award-info":[{"award-number":["2012\/14183-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303543\/2014-0"],"award-info":[{"award-number":["303543\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00109-019-01842-5","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T08:03:16Z","timestamp":1573545796000},"page":"39-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-1130","authenticated-orcid":false,"given":"Caio Jord\u00e3o","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-8618","authenticated-orcid":false,"given":"Katherine","family":"Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-8656","authenticated-orcid":false,"given":"Carla Roberta","family":"de Oliveira Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"10","key":"1842_CR1","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/GME.0000000000001136","volume":"25","author":"Jamal Hallajzadeh","year":"2018","unstructured":"Hallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi-Hashiani A, Ayubi E, Qorbani M, Pakzad R, Hasanzadeh A, Sullman MJM et al (2018) Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. https:\/\/doi.org\/10.1097\/GME.0000000000001136","journal-title":"Menopause"},{"issue":"2","key":"1842_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.17925\/EE.2014.10.02.136","volume":"10","author":"Robin P Shook","year":"2014","unstructured":"Shook RP, Blair SN, Duperly J, Hand GA, Matsudo SM, Slavin JL (2014) What is causing the worldwide rise in body weight? Eur Endocrinol 10: 136-144. DOI 10.17925\/EE.2014.10.02.136","journal-title":"European Endocrinology"},{"key":"1842_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsbmb.2015.07.008","volume":"153","author":"X Wang","year":"2015","unstructured":"Wang X, Simpson ER, Brown KA (2015) Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer. J Steroid Biochem Mol Biol 153:35\u201344","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1842_CR4","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","volume":"95","author":"RJ Santen","year":"2010","unstructured":"Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M et al (2010) Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95:s1\u2013s66","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","volume":"304","author":"RT Chlebowski","year":"2010","unstructured":"Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE et al (2010) Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 304:1684\u20131692","journal-title":"JAMA"},{"key":"1842_CR6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/GME.0000000000001232","volume":"25","author":"F Lalibert\u00e9","year":"2018","unstructured":"Lalibert\u00e9 F, Dea K, Duh MS, Kahler KH, Rolli M, Lefebvre P (2018) Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause 25:1297\u20131305","journal-title":"Menopause"},{"key":"1842_CR7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/rth2.12100","volume":"2","author":"M Cushman","year":"2018","unstructured":"Cushman M, Larson JC, Rosendaal FR, Heckbert SR, Curb JD, Phillips LS, Baird AE, Eaton CB, Stafford RS (2018) Biomarkers, menopausal hormone therapy and risk of venous thrombosis: the Women's Health Initiative. Res Pract Thromb Haemost 2:310\u2013319","journal-title":"Res Pract Thromb Haemost"},{"key":"1842_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124511","volume":"10","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Kang J, Chen D, Han N, Ma H (2015) Ample evidence: dehydroepiandrosterone (DHEA) conversion into activated steroid hormones occurs in adrenal and ovary in female rat. PLoS One 10:e0124511. https:\/\/doi.org\/10.1371\/journal.pone.0124511","journal-title":"PLoS One"},{"key":"1842_CR9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1210\/me.2009-0024","volume":"23","author":"LL Grasfeder","year":"2009","unstructured":"Grasfeder LL, Gaillard S, Hammes SR, Ilkayeva O, Newgard CB, Hochberg RB, Dwyer MA, Chang CY, McDonnell DP (2009) Fasting-induced hepatic production of DHEA is regulated by PGC-1alpha, ERRalpha, and HNF4alpha. Mol Endocrinol 23:1171\u20131182","journal-title":"Mol Endocrinol"},{"key":"1842_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/jcem-59-3-551","volume":"59","author":"N Orentreich","year":"1984","unstructured":"Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551\u2013555","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1043-2760(02)00609-4","volume":"13","author":"WE Rainey","year":"2002","unstructured":"Rainey WE, Carr BR, Sasano H, Suzuki T, Mason JI (2002) Dissecting human adrenal androgen production. Trends Endocrinol Metab 13:234\u2013239","journal-title":"Trends Endocrinol Metab"},{"key":"1842_CR12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00125-016-4136-8","volume":"60","author":"A Brahimaj","year":"2017","unstructured":"Brahimaj A, Muka T, Kavousi M, Laven JS, Dehghan A, Franco OH (2017) Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam study. Diabetologia 60:98\u2013106","journal-title":"Diabetologia"},{"key":"1842_CR13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0735-1097(10)80334-1","volume":"16","author":"DM Herrington","year":"1990","unstructured":"Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich PO, Pearson TA (1990) Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 16:862\u2013870","journal-title":"J Am Coll Cardiol"},{"key":"1842_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2265.1998.00533.x","volume":"49","author":"Y Yamaguchi","year":"1998","unstructured":"Yamaguchi Y, Tanaka S, Yamakawa T, Kimura M, Ukawa K, Yamada Y, Ishihara M, Sekihara H (1998) Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin Endocrinol 49:377\u2013383","journal-title":"Clin Endocrinol"},{"key":"1842_CR15","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.292.18.2243","volume":"292","author":"DT Villareal","year":"2004","unstructured":"Villareal DT, Holloszy JO (2004) Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292:2243\u20132248","journal-title":"JAMA"},{"issue":"5","key":"1842_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.18632\/aging.100327","volume":"3","author":"Edward P. Weiss","year":"2011","unstructured":"Weiss EP, Villareal DT, Fontana L, Han DH, Holloszy JO (2011) Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging (Albany NY) 3: 533-542. DOI https:\/\/doi.org\/10.18632\/aging.100327","journal-title":"Aging"},{"key":"1842_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.vh.2018.03.002","volume":"108","author":"K Sato","year":"2018","unstructured":"Sato K, Iemitsu M (2018) The role of dehydroepiandrosterone (DHEA) in skeletal muscle. Vitam Horm 108:205\u2013221","journal-title":"Vitam Horm"},{"key":"1842_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.fob.2014.01.005","volume":"4","author":"K Veras","year":"2014","unstructured":"Veras K, Almeida FN, Nachbar RT, de Jesus DS, Camporez JP, Carpinelli AR, Goedecke JH, de Oliveira Carvalho CR (2014) DHEA supplementation in ovariectomized rats reduces impaired glucose-stimulated insulin secretion induced by a high-fat diet. FEBS Open Bio 4:141\u2013146","journal-title":"FEBS Open Bio"},{"key":"1842_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159077","volume":"11","author":"J Kang","year":"2016","unstructured":"Kang J, Ge C, Yu L, Li L, Ma H (2016) Long-term administration of dehydroepiandrosterone accelerates glucose catabolism via activation of PI3K\/Akt-PFK-2 signaling pathway in rats fed a high-fat diet. PLoS One 11:e0159077. https:\/\/doi.org\/10.1371\/journal.pone.0159077","journal-title":"PLoS One"},{"key":"1842_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lfs.2004.06.017","volume":"76","author":"CS Campbell","year":"2004","unstructured":"Campbell CS, Caperuto LC, Hirata AE, Araujo EP, Velloso LA, Saad MJ, Carvalho CR (2004) The phosphatidylinositol\/AKT\/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo. Life Sci 76:57\u201370","journal-title":"Life Sci"},{"key":"1842_CR21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jnutbio.2007.10.005","volume":"19","author":"J S\u00e1nchez","year":"2008","unstructured":"S\u00e1nchez J, P\u00e9rez-Heredia F, Priego T, Portillo MP, Zamora S, Garaulet M, Palou A (2008) Dehydroepiandrosterone prevents age-associated alterations, increasing insulin sensitivity. J Nutr Biochem 19:809\u2013818","journal-title":"J Nutr Biochem"},{"key":"1842_CR22","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.4238\/2015.September.22.24","volume":"14","author":"FJ Yin","year":"2015","unstructured":"Yin FJ, Kang J, Han NN, Ma HT (2015) Effect of dehydroepiandrosterone treatment on hormone levels and antioxidant parameters in aged rats. Genet Mol Res 14:11300\u201311311","journal-title":"Genet Mol Res"},{"key":"1842_CR23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.steroids.2009.08.005","volume":"74","author":"MH Jacob","year":"2009","unstructured":"Jacob MH, Janner DR, Jahn MP, Kucharski LC, Bell\u00f3-Klein A, Ribeiro MF (2009) DHEA effects on myocardial Akt signaling modulation and oxidative stress changes in aged rats. Steroids 74:1045\u20131050","journal-title":"Steroids"},{"key":"1842_CR24","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1113\/jphysiol.2011.206078","volume":"589","author":"JP Camporez","year":"2011","unstructured":"Camporez JP, Akamine EH, Davel AP, Franci CR, Rossoni LV, Carvalho CR (2011) Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats. J Physiol 589:2585\u20132596","journal-title":"J Physiol"},{"key":"1842_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/aps.2008.2","volume":"30","author":"HH Cheng","year":"2009","unstructured":"Cheng HH, Hu XJ, Ruan QR (2009) Dehydroepiandrosterone anti-atherogenesis effect is not via its conversion to estrogen. Acta Pharmacol Sin 30:42\u201353","journal-title":"Acta Pharmacol Sin"},{"key":"1842_CR26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2265.2011.04306.x","volume":"77","author":"C G\u00f3mez-Santos","year":"2012","unstructured":"G\u00f3mez-Santos C, Hern\u00e1ndez-Morante JJ, T\u00e9bar FJ, Granero E, Garaulet M (2012) Differential effect of oral dehydroepiandrosterone-sulphate on metabolic syndrome features in pre- and postmenopausal obese women. Clin Endocrinol 77:548\u2013554","journal-title":"Clin Endocrinol"},{"key":"1842_CR27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1517\/14728220903264064","volume":"13","author":"MS Bhuiyan","year":"2009","unstructured":"Bhuiyan MS, Fukunaga K (2009) Stimulation of sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats. Expert Opin Ther Targets 13:1253\u20131265","journal-title":"Expert Opin Ther Targets"},{"key":"1842_CR28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2018.03.052","volume":"202","author":"CJ Teixeira","year":"2018","unstructured":"Teixeira CJ, Ribeiro LM, Veras K, da Cunha Araujo LC, Curi R, de Oliveira Carvalho CR (2018) Dehydroepiandrosterone supplementation is not beneficial in the late postmenopausal period in diet-induced obese rats. Life Sci 202:110\u2013116","journal-title":"Life Sci"},{"key":"1842_CR29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jcem-71-3-696","volume":"71","author":"JF Mortola","year":"1990","unstructured":"Mortola JF, Yen SS (1990) The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71:696\u2013704","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0960327115595706","volume":"35","author":"E Emer","year":"2016","unstructured":"Emer E, Yildiz O, Seyrek M, Demirkol S, Topal T, Kurt B, Sayal A (2016) High-dose testosterone and dehydroepiandrosterone induce cardiotoxicity in rats: assessment of echocardiographic, morphologic, and oxidative stress parameters. Hum Exp Toxicol 35:562\u2013572","journal-title":"Hum Exp Toxicol"},{"key":"1842_CR31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.maturitas.2009.03.020","volume":"63","author":"M Panjari","year":"2009","unstructured":"Panjari M, Bell RJ, Jane F, Adams J, Morrow C, Davis SR (2009) The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas 63:240\u2013245","journal-title":"Maturitas"},{"key":"1842_CR32","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jacc.2003.07.024","volume":"42","author":"MK Ng","year":"2003","unstructured":"Ng MK, Nakhla S, Baoutina A, Jessup W, Handelsman DJ, Celermajer DS (2003) Dehydroepiandrosterone, an adrenal androgen, increases human foam cell formation: a potentially pro-atherogenic effect. J Am Coll Cardiol 42:1967\u20131974","journal-title":"J Am Coll Cardiol"},{"key":"1842_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","volume":"64","author":"JS Klair","year":"2016","unstructured":"Klair JS, Yang JD, Abdelmalek MF, Guy CD, Gill RM, Yates K, Unalp-Arida A, Lavine JE, Clark JM, Diehl AM et al (2016) A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology 64:85\u201391","journal-title":"Hepatology"},{"key":"1842_CR34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1017\/S0007114514002517","volume":"112","author":"I C\u00f4t\u00e9","year":"2014","unstructured":"C\u00f4t\u00e9 I, Chapados NA, Lavoie JM (2014) Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat\/high-cholesterol diets? Br J Nutr 112:1592\u20131600","journal-title":"Br J Nutr"},{"key":"1842_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136143","volume":"10","author":"ML Van Sinderen","year":"2015","unstructured":"Van Sinderen ML, Steinberg GR, J\u00f8rgensen SB, Honeyman J, Chow JD, Herridge KA, Winship AL, Dimitriadis E, Jones ME, Simpson ER et al (2015) Effects of estrogens on adipokines and glucose homeostasis in female aromatase knockout mice. PLoS One 10:e0136143. https:\/\/doi.org\/10.1371\/journal.pone.0136143","journal-title":"PLoS One"},{"key":"1842_CR36","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1530\/JME-16-0013","volume":"56","author":"RA Prough","year":"2016","unstructured":"Prough RA, Clark BJ, Klinge CM (2016) Novel mechanisms for DHEA action. J Mol Endocrinol 56:R139\u2013R155","journal-title":"J Mol Endocrinol"},{"key":"1842_CR37","first-page":"65","volume":"14","author":"J Karbowska","year":"2013","unstructured":"Karbowska J, Kochan Z (2013) Effects of DHEA on metabolic and endocrine functions of adipose tissue. Horm Mol Biol Clin Invest 14:65\u201374","journal-title":"Horm Mol Biol Clin Invest"},{"key":"1842_CR38","doi-asserted-by":"crossref","first-page":"E1134","DOI":"10.1152\/ajpendo.00314.2012","volume":"305","author":"JC McNelis","year":"2013","unstructured":"McNelis JC, Manolopoulos KN, Gathercole LL, Bujalska IJ, Stewart PM, Tomlinson JW, Arlt W (2013) Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake. Am J Physiol Endocrinol Metab 305:E1134\u2013E1144","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1510001","volume":"151","author":"A Tchernof","year":"2004","unstructured":"Tchernof A, Labrie F (2004) Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 151:1\u201314","journal-title":"Eur J Endocrinol"},{"key":"1842_CR40","first-page":"1105","volume":"20","author":"G De Pergola","year":"1996","unstructured":"De Pergola G, Zamboni M, Sciaraffia M, Turcato E, Pannacciulli N, Armellini F, Giorgino F, Perrini S, Bosello O, Giorgino R (1996) Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women. Int J Obes Relat Metab Disord 20:1105\u20131110","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1842_CR41","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa054629","volume":"355","author":"KS Nair","year":"2006","unstructured":"Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R et al (2006) DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647\u20131659","journal-title":"N Engl J Med"},{"key":"1842_CR42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2265.2011.04073.x","volume":"75","author":"CM Jankowski","year":"2011","unstructured":"Jankowski CM, Gozansky WS, Van Pelt RE, Wolfe P, Schwartz RS, Kohrt WM (2011) Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids. Clin Endocrinol 75:456\u2013463","journal-title":"Clin Endocrinol"},{"key":"1842_CR43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jcem-66-1-57","volume":"66","author":"JE Nestler","year":"1988","unstructured":"Nestler JE, Barlascini CO, Clore JN, Blackard WG (1988) Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66:57\u201361","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR44","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.1093\/gerona\/53A.1.B19","volume":"53","author":"DH Han","year":"1998","unstructured":"Han DH, Hansen PA, Chen MM, Holloszy JO (1998) DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. J Gerontol A Biol Sci Med Sci 53:B19\u2013B24","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1842_CR45","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.steroids.2012.08.002","volume":"77","author":"J Karbowska","year":"2012","unstructured":"Karbowska J, Kochan Z (2012) Fat-reducing effects of dehydroepiandrosterone involve upregulation of ATGL and HSL expression, and stimulation of lipolysis in adipose tissue. Steroids 77:1359\u20131365","journal-title":"Steroids"},{"issue":"1","key":"1842_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/scipharm85010013","volume":"85","author":"Reza Hakkak","year":"2017","unstructured":"Hakkak R, Bell A, Korourian S (2017) Dehydroepiandrosterone (DHEA) feeding protects liver steatosis in obese breast cancer rat model. Sci Pharm 85. https:\/\/doi.org\/10.3390\/scipharm85010013","journal-title":"Scientia Pharmaceutica"},{"key":"1842_CR47","first-page":"R1704","volume":"273","author":"PA Hansen","year":"1997","unstructured":"Hansen PA, Han DH, Nolte LA, Chen M, Holloszy JO (1997) DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am J Phys 273:R1704\u2013R1708","journal-title":"Am J Phys"},{"key":"1842_CR48","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1152\/ajpendo.00112.2011","volume":"302","author":"K Fujioka","year":"2012","unstructured":"Fujioka K, Kajita K, Wu Z, Hanamoto T, Ikeda T, Mori I, Okada H, Yamauchi M, Uno Y, Morita H et al (2012) Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor. Am J Physiol Endocrinol Metab 302:E694\u2013E704","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR49","first-page":"R1374","volume":"268","author":"AR Tagliaferro","year":"1995","unstructured":"Tagliaferro AR, Ronan AM, Payne J, Meeker LD, Tse S (1995) Increased lipolysis to beta-adrenergic stimulation after dehydroepiandrosterone treatment in rats. Am J Phys 268:R1374\u2013R1380","journal-title":"Am J Phys"},{"key":"1842_CR50","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0007114507332546","volume":"97","author":"FP de Heredia","year":"2007","unstructured":"de Heredia FP, Cerezo D, Zamora S, Garaulet M (2007) Effect of dehydroepiandrosterone on protein and fat digestibility, body protein and muscular composition in high-fat-diet-fed old rats. Br J Nutr 97:464\u2013470","journal-title":"Br J Nutr"},{"key":"1842_CR51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2010.02.017","volume":"320","author":"SP Rice","year":"2010","unstructured":"Rice SP, Zhang L, Grennan-Jones F, Agarwal N, Lewis MD, Rees DA, Ludgate M (2010) Dehydroepiandrosterone (DHEA) treatment in vitro inhibits adipogenesis in human omental but not subcutaneous adipose tissue. Mol Cell Endocrinol 320:51\u201357","journal-title":"Mol Cell Endocrinol"},{"key":"1842_CR52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1006\/bbrc.1998.8996","volume":"248","author":"YR Lea-Currie","year":"1998","unstructured":"Lea-Currie YR, Wen P, McIntosh MK (1998) Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 248:497\u2013504","journal-title":"Biochem Biophys Res Commun"},{"key":"1842_CR53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0167-4889(91)90162-Q","volume":"1092","author":"J Yamada","year":"1991","unstructured":"Yamada J, Sakuma M, Ikeda T, Fukuda K, Suga T (1991) Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim Biophys Acta 1092:233\u2013243","journal-title":"Biochim Biophys Acta"},{"key":"1842_CR54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bcp.2005.04.022","volume":"70","author":"J Karbowska","year":"2005","unstructured":"Karbowska J, Kochan Z (2005) Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. Biochem Pharmacol 70:249\u2013257","journal-title":"Biochem Pharmacol"},{"key":"1842_CR55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/en.2002-220039","volume":"144","author":"K Kajita","year":"2003","unstructured":"Kajita K, Ishizuka T, Mune T, Miura A, Ishizawa M, Kanoh Y, Kawai Y, Natsume Y, Yasuda K (2003) Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. Endocrinology 144:253\u2013259","journal-title":"Endocrinology"},{"issue":"5","key":"1842_CR56","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/nu9050426","volume":"9","author":"Bal\u00e1zs Legeza","year":"2017","unstructured":"Legeza B, Marcolongo P, Gamberucci A, Varga V, B\u00e1nhegyi G, Benedetti A, Odermatt A (2017) Fructose, glucocorticoids and adipose tissue: implications for the metabolic syndrome. Nutrients 9. https:\/\/doi.org\/10.3390\/nu9050426","journal-title":"Nutrients"},{"key":"1842_CR57","doi-asserted-by":"crossref","first-page":"E957","DOI":"10.1152\/ajpendo.00442.2004","volume":"288","author":"G Apostolova","year":"2005","unstructured":"Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A (2005) Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. Am J Physiol Endocrinol Metab 288:E957\u2013E964","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR58","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.steroids.2011.09.005","volume":"76","author":"N Tagawa","year":"2011","unstructured":"Tagawa N, Minamitani E, Yamaguchi Y, Kobayashi Y (2011) Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue. Steroids 76:1546\u20131553","journal-title":"Steroids"},{"key":"1842_CR59","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2337\/diab.42.5.662","volume":"42","author":"JM Abadie","year":"1993","unstructured":"Abadie JM, Wright B, Correa G, Browne ES, Porter JR, Svec F (1993) Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. The Obesity Research Program Diabetes. Diabetes 42:662\u2013669","journal-title":"Diabetes"},{"key":"1842_CR60","first-page":"480","volume":"19","author":"JR Porter","year":"1995","unstructured":"Porter JR, Abadie JM, Wright BE, Browne ES, Svec F (1995) The effect of discontinuing dehydroepiandrosterone supplementation on Zucker rat food intake and hypothalamic neurotransmitters. Int J Obes Relat Metab Disord 19:480\u2013488","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1842_CR61","first-page":"887","volume":"19","author":"BE Wright","year":"1995","unstructured":"Wright BE, Svec F, Porter JR (1995) Central effects of dehydroepiandrosterone in Zucker rats. Int J Obes Relat Metab Disord 19:887\u2013892","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 1","key":"1842_CR62","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0306-4530(97)00004-8","volume":"22","author":"F Svec","year":"1997","unstructured":"Svec F, Porter J (1997) The effect of dehydroepiandrosterone (DHEA) on Zucker rat food selection and hypothalamic neurotransmitters. Psychoneuroendocrinology 22(Suppl 1):S57\u2013S62","journal-title":"Psychoneuroendocrinology"},{"key":"1842_CR63","first-page":"R928","volume":"288","author":"J Porter","year":"2005","unstructured":"Porter J, Van Vrancken M, Corll C, Thompson H, Svec F (2005) The influence of dehydroepiandrosterone and 8-OH-DPAT on the caloric intake and hypothalamic neurotransmitters of lean and obese Zucker rats. Am J Phys Regul Integr Comp Phys 288:R928\u2013R935","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"1842_CR64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0248-4900(91)90045-O","volume":"71","author":"EE Baulieu","year":"1991","unstructured":"Baulieu EE (1991) Neurosteroids: a new function in the brain. Biol Cell 71:3\u201310","journal-title":"Biol Cell"},{"key":"1842_CR65","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1210\/endo.143.5.8765","volume":"143","author":"D Beaujean","year":"2002","unstructured":"Beaujean D, Do-Rego JL, Galas L, Mensah-Nyagan AG, Fredriksson R, Larhammar D, Fournier A, Luu-The V, Pelletier G, Vaudry H (2002) Neuropeptide Y inhibits the biosynthesis of sulfated neurosteroids in the hypothalamus through activation of Y(1) receptors. Endocrinology 143:1950\u20131963","journal-title":"Endocrinology"},{"key":"1842_CR66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10284150601090102","volume":"9","author":"D Navar","year":"2006","unstructured":"Navar D, Saulis D, Corll C, Svec F, Porter JR (2006) Dehydroepiandrosterone (DHEA) blocks the increase in food intake caused by neuropeptide Y (NPY) in the Zucker rat. Nutr Neurosci 9:225\u2013232","journal-title":"Nutr Neurosci"},{"key":"1842_CR67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0031-9384(93)90008-4","volume":"53","author":"BE Wright","year":"1993","unstructured":"Wright BE, Browne ES, Svec F, Porter JR (1993) Divergent effect of dehydroepiandrosterone on energy intakes of Zucker rats. Physiol Behav 53:39\u201343","journal-title":"Physiol Behav"},{"key":"1842_CR68","first-page":"326","volume":"221","author":"F Catalina","year":"1999","unstructured":"Catalina F, Kumar V, Milewich L, Bennett M (1999) Food restriction-like effects of dehydroepiandrosterone: decreased lymphocyte numbers and functions with increased apoptosis. Proc Soc Exp Biol Med 221:326\u2013335","journal-title":"Proc Soc Exp Biol Med"},{"key":"1842_CR69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0531-5565(84)90002-0","volume":"19","author":"R Weindruch","year":"1984","unstructured":"Weindruch R, McFeeters G, Walford RL (1984) Food intake reduction and immunologic alterations in mice fed dehydroepiandrosterone. Exp Gerontol 19:297\u2013304","journal-title":"Exp Gerontol"},{"key":"1842_CR70","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/153537020122600308","volume":"226","author":"F Catalina","year":"2001","unstructured":"Catalina F, Speciale SG, Kumar V, Milewich L, Bennett M (2001) Food restriction-like effects of dietary dehydroepiandrosterone. Hypothalamic neurotransmitters and metabolites in male C57BL\/6 and (C57BL\/6 x DBA\/2)F1 mice. Exp Biol Med (Maywood) 226:208\u2013215","journal-title":"Exp Biol Med (Maywood)"},{"key":"1842_CR71","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7150\/ijms.23352","volume":"15","author":"YM Chen","year":"2018","unstructured":"Chen YM, Lee HC, Chen MT, Huang CC, Chen WC (2018) Dehydroepiandrosterone supplementation combined with weight-loading whole-body vibration training (WWBV) affects exercise performance and muscle glycogen storage in middle-aged C57BL\/6 mice. Int J Med Sci 15:564\u2013573","journal-title":"Int J Med Sci"},{"key":"1842_CR72","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0006-291X(03)00409-1","volume":"303","author":"JW Ryu","year":"2003","unstructured":"Ryu JW, Kim MS, Kim CH, Song KH, Park JY, Lee JD, Kim JB, Lee KU (2003) DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF rats. Biochem Biophys Res Commun 303:726\u2013731","journal-title":"Biochem Biophys Res Commun"},{"key":"1842_CR73","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/jn\/116.10.1977","volume":"116","author":"AR Tagliaferro","year":"1986","unstructured":"Tagliaferro AR, Davis JR, Truchon S, Van Hamont N (1986) Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. J Nutr 116:1977\u20131983","journal-title":"J Nutr"},{"key":"1842_CR74","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1152\/japplphysiol.00541.2010","volume":"110","author":"BK Gorres","year":"1985","unstructured":"Gorres BK, Bomhoff GL, Gupte AA (1985) Geiger PC (2011) Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet. J Appl Physiol 110:1046\u20131053","journal-title":"J Appl Physiol"},{"key":"1842_CR75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/toxsci\/kfl064","volume":"93","author":"D Safiulina","year":"2006","unstructured":"Safiulina D, Peet N, Seppet E, Zharkovsky A, Kaasik A (2006) Dehydroepiandrosterone inhibits complex I of the mitochondrial respiratory chain and is neurotoxic in vitro and in vivo at high concentrations. Toxicol Sci 93:348\u2013356","journal-title":"Toxicol Sci"},{"key":"1842_CR76","first-page":"1021","volume":"25","author":"D Mayer","year":"2004","unstructured":"Mayer D, Forstner K (2004) Impact of dehydroepiandrosterone on hepatocarcinogenesis in the rat (Review). Int J Oncol 25:1021\u20131030","journal-title":"Int J Oncol"},{"key":"1842_CR77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS (2017) Inflammation, metaflammation and immunometabolic disorders. Nature 542:177\u2013185","journal-title":"Nature"},{"key":"1842_CR78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415\u2013445","journal-title":"Annu Rev Immunol"},{"key":"1842_CR79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1748-1716.2009.02011.x","volume":"197","author":"K Sato","year":"2009","unstructured":"Sato K, Iemitsu M, Aizawa K, Ajisaka R (2009) DHEA improves impaired activation of Akt and PKC zeta\/lambda-GLUT4 pathway in skeletal muscle and improves hyperglycaemia in streptozotocin-induced diabetes rats. Acta Physiol (Oxford) 197:217\u2013225","journal-title":"Acta Physiol (Oxford)"},{"key":"1842_CR80","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","volume":"296","author":"S Boura-Halfon","year":"2009","unstructured":"Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581\u2013E591","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR81","doi-asserted-by":"crossref","first-page":"11013","DOI":"10.1038\/s41598-018-29044-y","volume":"8","author":"LCC Araujo","year":"2018","unstructured":"Araujo LCC, Feitosa KB, Murata GM, Furigo IC, Teixeira SA, Lucena CF, Ribeiro LM, Muscar\u00e1 MN, Costa SKP, Donato J et al (2018) Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD. Sci Rep 8:11013","journal-title":"Sci Rep"},{"key":"1842_CR82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsbmb.2011.07.007","volume":"127","author":"MH Jacob","year":"2011","unstructured":"Jacob MH, Janner DR, Ara\u00fajo AS, Jahn MP, Kucharski LC, Moraes TB, Dutra Filho CS, Ribeiro MF, Bell\u00f3-Klein A (2011) Dehydroepiandrosterone improves hepatic antioxidant reserve and stimulates Akt signaling in young and old rats. J Steroid Biochem Mol Biol 127:331\u2013336","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1842_CR83","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jsbmb.2016.03.011","volume":"159","author":"K Aoki","year":"2016","unstructured":"Aoki K, Tajima K, Taguri M, Terauchi Y (2016) Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKC\u03b6) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1(-\/-), and IRS2(-\/-) male mice fed a high-fat diet. J Steroid Biochem Mol Biol 159:110\u2013120","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1842_CR84","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12020-014-0396-6","volume":"48","author":"AL Cecconello","year":"2015","unstructured":"Cecconello AL, Trapp M, Hoefel AL, Marques CV, Arbo BD, Osterkamp G, Kucharski LC, Ribeiro MF (2015) Sex-related differences in the effects of high-fat diets on DHEA-treated rats. Endocrine 48:985\u2013994","journal-title":"Endocrine"},{"key":"1842_CR85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2010.03.015","volume":"120","author":"MP Jahn","year":"2010","unstructured":"Jahn MP, Jacob MH, Gomes LF, Duarte R, Ara\u00fajo AS, Bell\u00f3-Klein A, Ribeiro MF, Kucharski LC (2010) The effect of long-term DHEA treatment on glucose metabolism, hydrogen peroxide and thioredoxin levels in the skeletal muscle of diabetic rats. J Steroid Biochem Mol Biol 120:38\u201344","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1842_CR86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-7075-9-47","volume":"9","author":"K Sato","year":"2012","unstructured":"Sato K, Iemitsu M, Aizawa K, Mesaki N, Ajisaka R, Fujita S (2012) DHEA administration and exercise training improves insulin resistance in obese rats. Nutr Metab (Lond) 9:47","journal-title":"Nutr Metab (Lond)"},{"key":"1842_CR87","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1152\/ajpendo.00564.2010","volume":"301","author":"K Sato","year":"2011","unstructured":"Sato K, Iemitsu M, Aizawa K, Mesaki N, Fujita S (2011) Increased muscular dehydroepiandrosterone levels are associated with improved hyperglycemia in obese rats. Am J Physiol Endocrinol Metab 301:E274\u2013E280","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR88","first-page":"E196","volume":"276","author":"T Ishizuka","year":"1999","unstructured":"Ishizuka T, Kajita K, Miura A, Ishizawa M, Kanoh Y, Itaya S, Kimura M, Muto N, Mune T, Morita H et al (1999) DHEA improves glucose uptake via activations of protein kinase C and phosphatidylinositol 3-kinase. Am J Phys 276:E196\u2013E204","journal-title":"Am J Phys"},{"key":"1842_CR89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00592-007-0009-4","volume":"44","author":"T Ishizuka","year":"2007","unstructured":"Ishizuka T, Miura A, Kajita K, Matsumoto M, Sugiyama C, Matsubara K, Ikeda T, Mori I, Morita H, Uno Y et al (2007) Effect of dehydroepiandrosterone on insulin sensitivity in Otsuka Long-Evans Tokushima-fatty rats. Acta Diabetol 44:219\u2013226","journal-title":"Acta Diabetol"},{"key":"1842_CR90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/bbrc.2000.3677","volume":"277","author":"K Kajita","year":"2000","unstructured":"Kajita K, Ishizuka T, Miura A, Ishizawa M, Kanoh Y, Yasuda K (2000) The role of atypical and conventional PKC in dehydroepiandrosterone-induced glucose uptake and dexamethasone-induced insulin resistance. Biochem Biophys Res Commun 277:361\u2013367","journal-title":"Biochem Biophys Res Commun"},{"key":"1842_CR91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/diabetes.53.1.41","volume":"53","author":"S Perrini","year":"2004","unstructured":"Perrini S, Natalicchio A, Laviola L, Belsanti G, Montrone C, Cignarelli A, Minielli V, Grano M, De Pergola G, Giorgino R et al (2004) Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 53:41\u201352","journal-title":"Diabetes"},{"issue":"11","key":"1842_CR92","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1139\/cjpp-2018-0159","volume":"96","author":"Ana L\u00facia Hoefel","year":"2018","unstructured":"Hoefel AL, Arbo BD, Vieira-Marques C, Cecconello AL, Cozer AG, Ribeiro MFM, Kucharski LC (2018) Female rats are more susceptible to metabolic effects of dehydroepiandrosterone treatment. Can J Physiol Pharmacol:1\u20137. https:\/\/doi.org\/10.1139\/cjpp-2018-0159","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"1842_CR93","doi-asserted-by":"publisher","unstructured":"Adeva-Andany MM, P\u00e9rez-Felpete N, Fern\u00e1ndez-Fern\u00e1ndez C, Donapetry-Garc\u00eda C, Pazos-Garc\u00eda C (2016) Liver glucose metabolism in humans. Biosci Rep 36. https:\/\/doi.org\/10.1042\/BSR20160385","DOI":"10.1042\/BSR20160385"},{"key":"1842_CR94","doi-asserted-by":"crossref","first-page":"730","DOI":"10.7150\/ijms.16132","volume":"13","author":"WC Chen","year":"2016","unstructured":"Chen WC, Chen YM, Huang CC, Tzeng YD (2016) Dehydroepiandrosterone supplementation combined with whole-body vibration training affects testosterone level and body composition in mice. Int J Med Sci 13:730\u2013740","journal-title":"Int J Med Sci"},{"key":"1842_CR95","first-page":"1069","volume":"8","author":"D Mayer","year":"1996","unstructured":"Mayer D, Reuter S, Hoffmann H, Bocker T, Bannasch P (1996) Dehydroepiandrosterone reduces expression of glycolytic and gluconeogenic enzymes in the liver of male and female rats. Int J Oncol 8:1069\u20131078","journal-title":"Int J Oncol"},{"key":"1842_CR96","doi-asserted-by":"crossref","first-page":"E961","DOI":"10.1152\/ajpendo.00678.2007","volume":"294","author":"K Sato","year":"2008","unstructured":"Sato K, Iemitsu M, Aizawa K, Ajisaka R (2008) Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am J Physiol Endocrinol Metab 294:E961\u2013E968","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR97","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00652.2005","volume":"291","author":"CC Greenberg","year":"2006","unstructured":"Greenberg CC, Jurczak MJ, Danos AM, Brady MJ (2006) Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways. Am J Physiol Endocrinol Metab 291:E1\u2013E8","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR98","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1507\/endocrj.47.799","volume":"47","author":"K Aoki","year":"2000","unstructured":"Aoki K, Kikuchi T, Mukasa K, Ito S, Nakajima A, Satoh S, Okamura A, Sekihara H (2000) Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL\/KsJ-db\/db mice: comparison with troglitazone. Endocr J 47:799\u2013804","journal-title":"Endocr J"},{"key":"1842_CR99","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2337\/diabetes.48.8.1579","volume":"48","author":"K Aoki","year":"1999","unstructured":"Aoki K, Saito T, Satoh S, Mukasa K, Kaneshiro M, Kawasaki S, Okamura A, Sekihara H (1999) Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL\/Ksj-db\/db mice: comparison with troglitazone. Diabetes 48:1579\u20131585","journal-title":"Diabetes"},{"key":"1842_CR100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1507\/endocrj.52.727","volume":"52","author":"R Yamashita","year":"2005","unstructured":"Yamashita R, Saito T, Satoh S, Aoki K, Kaburagi Y, Sekihara H (2005) Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2. Endocr J 52:727\u2013733","journal-title":"Endocr J"},{"key":"1842_CR101","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.lfs.2003.10.031","volume":"74","author":"K Aoki","year":"2004","unstructured":"Aoki K, Taniguchi H, Ito Y, Satoh S, Nakamura S, Muramatsu K, Yamashita R, Ito S, Mori Y, Sekihara H (2004) Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL\/KsJ-db\/db mice. Life Sci 74:3075\u20133084","journal-title":"Life Sci"},{"key":"1842_CR102","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/jn\/121.12.2037","volume":"121","author":"MK McIntosh","year":"1991","unstructured":"McIntosh MK, Berdanier CD (1991) Antiobesity effects of dehydroepiandrosterone are mediated by futile substrate cycling in hepatocytes of BHE\/cdb rats. J Nutr 121:2037\u20132043","journal-title":"J Nutr"},{"key":"1842_CR103","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/diabetes.49.12.2012","volume":"49","author":"JS Dillon","year":"2000","unstructured":"Dillon JS, Yaney GC, Zhou Y, Voilley N, Bowen S, Chipkin S, Bliss CR, Schultz V, Schuit FC, Prentki M et al (2000) Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes 49:2012\u20132020","journal-title":"Diabetes"},{"key":"1842_CR104","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbrc.2013.10.002","volume":"440","author":"J Yue","year":"2013","unstructured":"Yue J, Wang L, Huang R, Li S, Ma J, Teng X, Liu W (2013) Dehydroepiandrosterone-sulfate (DHEAS) promotes MIN6 cells insulin secretion via inhibition of AMP-activated protein kinase. Biochem Biophys Res Commun 440:756\u2013761","journal-title":"Biochem Biophys Res Commun"},{"key":"1842_CR105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5171\/2013.675769","volume":"2013","author":"FN Almeida","year":"2013","unstructured":"Almeida FN, Veras KM, Camporez JP, Felitti V, Chimin P, Carvalho CRO (2013) Dehydroepiandrosterone increases pancreatic duodenal homebox-1 (PDX-1) and reduces cleaved caspase-3 protein expression in insulin-secreting INS-1E cells. Research in Endocrinology. ENDO 2013:1\u20138","journal-title":"ENDO"},{"key":"1842_CR106","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbrc.2018.04.134","volume":"500","author":"J Ma","year":"2018","unstructured":"Ma J, Yue J, Huang R, Liao Y, Li S, Liu W (2018) Reversion of aging-related DHEAS decline in mouse plasma alleviates aging-related glucose tolerance impairment by potentiation of glucose-stimulated insulin secretion of acute phase. Biochem Biophys Res Commun 500:671\u2013675","journal-title":"Biochem Biophys Res Commun"},{"key":"1842_CR107","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/bmme.1997.2581","volume":"61","author":"MH Giroix","year":"1997","unstructured":"Giroix MH, Malaisse-Lagae F, Portha B, Sener A, Malaisse WJ (1997) Effects of dehydroepiandrosterone in rats injected with streptozotocin during the neonatal period. Biochem Mol Med 61:72\u201381","journal-title":"Biochem Mol Med"},{"key":"1842_CR108","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2337\/diab.31.9.830","volume":"31","author":"DL Coleman","year":"1982","unstructured":"Coleman DL, Leiter EH, Schwizer RW (1982) Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31:830\u2013833","journal-title":"Diabetes"},{"key":"1842_CR109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3181\/00379727-180-42158","volume":"180","author":"TS Gansler","year":"1985","unstructured":"Gansler TS, Muller S, Cleary MP (1985) Chronic administration of dehydroepiandrosterone reduces pancreatic beta-cell hyperplasia and hyperinsulinemia in genetically obese Zucker rats. Proc Soc Exp Biol Med 180:155\u2013162","journal-title":"Proc Soc Exp Biol Med"},{"key":"1842_CR110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.febslet.2005.12.014","volume":"580","author":"MC Medina","year":"2006","unstructured":"Medina MC, Souza LC, Caperuto LC, Anh\u00ea GF, Amanso AM, Teixeira VP, Bordin S, Carpinelli AR, Britto LR, Barbieri RL et al (2006) Dehydroepiandrosterone increases beta-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats. FEBS Lett 580:285\u2013290","journal-title":"FEBS Lett"},{"key":"1842_CR111","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1530\/eje.0.1450457","volume":"145","author":"A Lasco","year":"2001","unstructured":"Lasco A, Frisina N, Morabito N, Gaudio A, Morini E, Trifiletti A, Basile G, Nicita-Mauro V, Cucinotta D (2001) Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur J Endocrinol 145:457\u2013461","journal-title":"Eur J Endocrinol"},{"key":"1842_CR112","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1474-9726.2012.00852.x","volume":"11","author":"EP Weiss","year":"2012","unstructured":"Weiss EP, Villareal DT, Ehsani AA, Fontana L, Holloszy JO (2012) Dehydroepiandrosterone replacement therapy in older adults improves indices of arterial stiffness. Aging Cell 11:876\u2013884","journal-title":"Aging Cell"},{"key":"1842_CR113","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diabetes.54.3.765","volume":"54","author":"K Dhatariya","year":"2005","unstructured":"Dhatariya K, Bigelow ML, Nair KS (2005) Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 54:765\u2013769","journal-title":"Diabetes"},{"key":"1842_CR114","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1210\/endo.139.7.6118","volume":"139","author":"M Kimura","year":"1998","unstructured":"Kimura M, Tanaka S, Yamada Y, Kiuchi Y, Yamakawa T, Sekihara H (1998) Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology 139:3249\u20133253","journal-title":"Endocrinology"},{"key":"1842_CR115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.steroids.2006.04.001","volume":"71","author":"D Liu","year":"2006","unstructured":"Liu D, Ren M, Bing X, Stotts C, Deorah S, Love-Homan L, Dillon JS (2006) Dehydroepiandrosterone inhibits intracellular calcium release in beta-cells by a plasma membrane-dependent mechanism. Steroids 71:691\u2013699","journal-title":"Steroids"},{"key":"1842_CR116","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1210\/endo.137.8.8754764","volume":"137","author":"SG Laychock","year":"1996","unstructured":"Laychock SG, Bauer AL (1996) Epiandrosterone and dehydroepiandrosterone affect glucose oxidation and interleukin-1 beta effects in pancreatic islets. Endocrinology 137:3375\u20133385","journal-title":"Endocrinology"},{"key":"1842_CR117","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0006-2952(97)00666-7","volume":"55","author":"SG Laychock","year":"1998","unstructured":"Laychock SG (1998) Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1 beta. Biochem Pharmacol 55:1453\u20131464","journal-title":"Biochem Pharmacol"},{"key":"1842_CR118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10540-006-9001-4","volume":"26","author":"HK Liu","year":"2006","unstructured":"Liu HK, Green BD, McClenaghan NH, McCluskey JT, Flatt PR (2006) Deleterious effects of supplementation with dehydroepiandrosterone sulphate or dexamethasone on rat insulin-secreting cells under in vitro culture condition. Biosci Rep 26:31\u201338","journal-title":"Biosci Rep"},{"key":"1842_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024507","volume":"6","author":"E Rebelato","year":"2011","unstructured":"Rebelato E, Abdulkader F, Curi R, Carpinelli AR (2011) Control of the intracellular redox state by glucose participates in the insulin secretion mechanism. PLoS One 6:e24507. https:\/\/doi.org\/10.1371\/journal.pone.0024507","journal-title":"PLoS One"},{"key":"1842_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158166","volume":"11","author":"AC Munhoz","year":"2016","unstructured":"Munhoz AC, Riva P, Sim\u00f5es D, Curi R, Carpinelli AR (2016) Control of Insulin Secretion by production of reactive oxygen species: study performed in pancreatic islets from fed and 48-hour fasted Wistar rats. PLoS One 11:e0158166. https:\/\/doi.org\/10.1371\/journal.pone.0158166","journal-title":"PLoS One"},{"key":"1842_CR121","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/BJ20121349","volume":"450","author":"P Sp\u00e9gel","year":"2013","unstructured":"Sp\u00e9gel P, Sharoyko VV, Goehring I, Danielsson AP, Malmgren S, Nagorny CL, Andersson LE, Koeck T, Sharp GW, Straub SG et al (2013) Time-resolved metabolomics analysis of \u03b2-cells implicates the pentose phosphate pathway in the control of insulin release. Biochem J 450:595\u2013605","journal-title":"Biochem J"},{"key":"1842_CR122","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1096\/fj.09-136572","volume":"24","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Liew CW, Handy DE, Zhang Y, Leopold JA, Hu J, Guo L, Kulkarni RN, Loscalzo J, Stanton RC (2010) High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis. FASEB J 24:1497\u20131505","journal-title":"FASEB J"},{"issue":"9","key":"1842_CR123","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.bbamcr.2016.05.016","volume":"1863","author":"Zishui Fang","year":"2016","unstructured":"Fang Z, Jiang C, Feng Y, Chen R, Lin X, Zhang Z, Han L, Chen X, Li H, Guo Y, et al. (2016) Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells. Biochim Biophys Acta 1863: 2245-2254. DOI https:\/\/doi.org\/10.1016\/j.bbamcr.2016.05.016","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"1842_CR124","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/bjc.1997.102","volume":"75","author":"M Di Monaco","year":"1997","unstructured":"Di Monaco M, Pizzini A, Gatto V, Leonardi L, Gallo M, Brignardello E, Boccuzzi G (1997) Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. Br J Cancer 75:589\u2013592","journal-title":"Br J Cancer"},{"key":"1842_CR125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0039-128X(02)00117-4","volume":"68","author":"S Yoshida","year":"2003","unstructured":"Yoshida S, Honda A, Matsuzaki Y, Fukushima S, Tanaka N, Takagiwa A, Fujimoto Y, Miyazaki H, Salen G (2003) Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. Steroids 68:73\u201383","journal-title":"Steroids"},{"key":"1842_CR126","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.jacc.2018.01.083","volume":"71","author":"D Zhao","year":"2018","unstructured":"Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Lima JA, Allison MA, Shah SJ, Bertoni AG et al (2018) Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol 71:2555\u20132566","journal-title":"J Am Coll Cardiol"},{"key":"1842_CR127","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/13697137.2012.733983","volume":"16","author":"F Labrie","year":"2013","unstructured":"Labrie F, Labrie C (2013) DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric 16:205\u2013213","journal-title":"Climacteric"},{"key":"1842_CR128","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","volume":"90","author":"SL Davison","year":"2005","unstructured":"Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847\u20133853","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2017.11.006","volume":"108","author":"V Subramanya","year":"2018","unstructured":"Subramanya V, Zhao D, Ouyang P, Lima JA, Vaidya D, Ndumele CE, Bluemke DA, Shah SJ, Guallar E, Nwabuo CC et al (2018) Sex hormone levels and change in left ventricular structure among men and post-menopausal women: the multi-ethnic study of atherosclerosis (MESA). Maturitas 108:37\u201344","journal-title":"Maturitas"},{"key":"1842_CR130","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1210\/jc.2010-0143","volume":"95","author":"C Shufelt","year":"2010","unstructured":"Shufelt C, Bretsky P, Almeida CM, Johnson BD, Shaw LJ, Azziz R, Braunstein GD, Pepine CJ, Bittner V, Vido DA et al (2010) DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 95:4985\u20134992","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR131","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/STROKEAHA.111.000485","volume":"44","author":"MC Jim\u00e9nez","year":"2013","unstructured":"Jim\u00e9nez MC, Sun Q, Sch\u00fcrks M, Chiuve S, Hu FB, Manson JE, Rexrode KM (2013) Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 44:1784\u20131789","journal-title":"Stroke"},{"key":"1842_CR132","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/ageing\/afq043","volume":"39","author":"RS Boxer","year":"2010","unstructured":"Boxer RS, Kleppinger A, Brindisi J, Feinn R, Burleson JA, Kenny AM (2010) Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics. Age Ageing 39:451\u2013458","journal-title":"Age Ageing"},{"key":"1842_CR133","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/gerona\/61.9.957","volume":"61","author":"AR Cappola","year":"2006","unstructured":"Cappola AR, Xue QL, Walston JD, Leng SX, Ferrucci L, Guralnik J, Fried LP (2006) DHEAS levels and mortality in disabled older women: the Women's Health and Aging Study I. J Gerontol A Biol Sci Med Sci 61:957\u2013962","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1842_CR134","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2010.05.011","volume":"212","author":"S Yoshida","year":"2010","unstructured":"Yoshida S, Aihara K, Azuma H, Uemoto R, Sumitomo-Ueda Y, Yagi S, Ikeda Y, Iwase T, Nishio S, Kawano H et al (2010) Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function. Atherosclerosis 212:310\u2013315","journal-title":"Atherosclerosis"},{"key":"1842_CR135","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.91.6.1757","volume":"91","author":"E Barrett-Connor","year":"1995","unstructured":"Barrett-Connor E, Goodman-Gruen D (1995) Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women: The Rancho Bernardo Study. Circulation 91:1757\u20131760","journal-title":"Circulation"},{"key":"1842_CR136","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1373\/clinchem.2007.099291","volume":"54","author":"JH Page","year":"2008","unstructured":"Page JH, Ma J, Rexrode KM, Rifai N, Manson JE, Hankinson SE (2008) Plasma dehydroepiandrosterone and risk of myocardial infarction in women. Clin Chem 54:1190\u20131196","journal-title":"Clin Chem"},{"key":"1842_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/757461","volume":"2014","author":"Fernando Lizcano","year":"2014","unstructured":"Lizcano F, Guzm\u00e1n G (2014) Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int 2014: 757461. DOI https:\/\/doi.org\/10.1155\/2014\/757461","journal-title":"BioMed Research International"},{"key":"1842_CR138","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1210\/jc.2003-030242","volume":"88","author":"MC Carr","year":"2003","unstructured":"Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88:2404\u20132411","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2015.07.001","volume":"72","author":"A Stefanska","year":"2015","unstructured":"Stefanska A, Bergmann K, Sypniewska G (2015) Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significancE. Adv Clin Chem 72:1\u201375","journal-title":"Adv Clin Chem"},{"key":"1842_CR140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0030-1262902","volume":"28","author":"HN Polotsky","year":"2010","unstructured":"Polotsky HN, Polotsky AJ (2010) Metabolic implications of menopause. Semin Reprod Med 28:426\u2013434","journal-title":"Semin Reprod Med"},{"key":"1842_CR141","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/13697137.2012.700743","volume":"15","author":"G Camilleri","year":"2012","unstructured":"Camilleri G, Borg M, Brincat S, Schembri-Wismayer P, Brincat M, Calleja-Agius J (2012) The role of cytokines in cardiovascular disease in menopause. Climacteric 15:524\u2013530","journal-title":"Climacteric"},{"key":"1842_CR142","first-page":"e25-146","volume":"117","author":"W Rosamond","year":"2008","unstructured":"Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B et al (2008) Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25-146","journal-title":"Circulation"},{"key":"1842_CR143","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","volume":"116","author":"P Lefebvre","year":"2006","unstructured":"Lefebvre P, Chinetti G, Fruchart JC, Staels B (2006) Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116:571\u2013580","journal-title":"J Clin Invest"},{"key":"1842_CR144","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1155\/2013\/724706","volume":"35","author":"F Mascarenhas-Melo","year":"2013","unstructured":"Mascarenhas-Melo F, Sereno J, Teixeira-Lemos E, Ribeiro S, Rocha-Pereira P, Cotterill E, Teixeira F, Reis F (2013) Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations. Dis Markers 35:85\u201396","journal-title":"Dis Markers"},{"key":"1842_CR145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.mcna.2015.01.007","volume":"99","author":"SK Gill","year":"2015","unstructured":"Gill SK (2015) Cardiovascular risk factors and disease in women. Med Clin North Am 99:535\u2013552","journal-title":"Med Clin North Am"},{"key":"1842_CR146","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00005344-199511000-00017","volume":"26","author":"T Hayashi","year":"1995","unstructured":"Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G (1995) Gender differences in atherosclerosis: possible role of nitric oxide. J Cardiovasc Pharmacol 26:792\u2013802","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 1","key":"1842_CR147","first-page":"515","volume":"44","author":"PM Sarrel","year":"1999","unstructured":"Sarrel PM (1999) Risks and benefits of hormone replacement therapy for the prevention of cardiovascular disease. Cardiologia 44(Suppl 1):515\u2013518","journal-title":"Cardiologia"},{"key":"1842_CR148","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","volume":"8","author":"A Iorga","year":"2017","unstructured":"Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M (2017) The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 8:33","journal-title":"Biol Sex Differ"},{"issue":"6","key":"1842_CR149","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/1570161116666180709095348","volume":"17","author":"Panagiotis Anagnostis","year":"2019","unstructured":"Anagnostis P, Paschou SA, Katsiki N, Krikidis D, Lambrinoudaki I, Goulis DG (2018) Menopausal hormone therapy and cardiovascular risk. Where are we now? Curr Vasc Pharmacol. https:\/\/doi.org\/10.2174\/1570161116666180709095348","journal-title":"Current Vascular Pharmacology"},{"issue":"Suppl","key":"1842_CR150","first-page":"S43","volume":"150","author":"P Diamond","year":"1996","unstructured":"Diamond P, Cusan L, Gomez JL, B\u00e9langer A, Labrie F (1996) Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150(Suppl):S43\u2013S50","journal-title":"J Endocrinol"},{"key":"1842_CR151","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0015-0282(98)00121-6","volume":"70","author":"PR Casson","year":"1998","unstructured":"Casson PR, Santoro N, Elkind-Hirsch K, Carson SA, Hornsby PJ, Abraham G, Buster JE (1998) Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril 70:107\u2013110","journal-title":"Fertil Steril"},{"key":"1842_CR152","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20154655","volume":"49","author":"MV Borgo","year":"2016","unstructured":"Borgo MV, Claudio ER, Silva FB, Romero WG, Gouvea SA, Moys\u00e9s MR, Santos RL, Almeida SA, Podratz PL, Graceli JB et al (2016) Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats. Braz J Med Biol Res 49:e4655. https:\/\/doi.org\/10.1590\/1414-431X20154655","journal-title":"Braz J Med Biol Res"},{"key":"1842_CR153","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.CIR.103.3.435","volume":"103","author":"S Wassmann","year":"2001","unstructured":"Wassmann S, B\u00e4umer AT, Strehlow K, van Eickels M, Groh\u00e9 C, Ahlbory K, R\u00f6sen R, B\u00f6hm M, Nickenig G (2001) Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103:435\u2013441","journal-title":"Circulation"},{"key":"1842_CR154","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1515\/cclm-2015-0807","volume":"54","author":"C Cervellati","year":"2016","unstructured":"Cervellati C, Bergamini CM (2016) Oxidative damage and the pathogenesis of menopause related disturbances and diseases. Clin Chem Lab Med 54:739\u2013753","journal-title":"Clin Chem Lab Med"},{"key":"1842_CR155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mad.2017.04.002","volume":"164","author":"OA Rangel-Zu\u00f1iga","year":"2017","unstructured":"Rangel-Zu\u00f1iga OA, Cruz-Teno C, Haro C, Quintana-Navarro GM, Camara-Martos F, Perez-Martinez P, Garcia-Rios A, Garaulet M, Tena-Sempere M, Lopez-Miranda J et al (2017) Differential menopause- versus aging-induced changes in oxidative stress and circadian rhythm gene markers. Mech Ageing Dev 164:41\u201348","journal-title":"Mech Ageing Dev"},{"key":"1842_CR156","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arr.2009.07.002","volume":"9","author":"MD Herrera","year":"2010","unstructured":"Herrera MD, Mingorance C, Rodr\u00edguez-Rodr\u00edguez R, Alvarez de Sotomayor M (2010) Endothelial dysfunction and aging: an update. Ageing Res Rev 9:142\u2013152","journal-title":"Ageing Res Rev"},{"key":"1842_CR157","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.CIR.87.1.261","volume":"87","author":"DM Eich","year":"1993","unstructured":"Eich DM, Nestler JE, Johnson DE, Dworkin GH, Ko D, Wechsler AS, Hess ML (1993) Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 87:261\u2013269","journal-title":"Circulation"},{"key":"1842_CR158","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.ATV.9.2.159","volume":"9","author":"Y Arad","year":"1989","unstructured":"Arad Y, Badimon JJ, Badimon L, Hembree WC, Ginsberg HN (1989) Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. Arteriosclerosis 9:159\u2013166","journal-title":"Arteriosclerosis"},{"key":"1842_CR159","first-page":"712","volume":"82","author":"GB Gordon","year":"1988","unstructured":"Gordon GB, Bush DE, Weisman HF (1988) Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury J Clin Invest 82:712\u2013720","journal-title":"A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury J Clin Invest"},{"key":"1842_CR160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2010.07.043","volume":"214","author":"L Wang","year":"2011","unstructured":"Wang L, Hao Q, Wang YD, Wang WJ, Li DJ (2011) Protective effects of dehydroepiandrosterone on atherosclerosis in ovariectomized rabbits via alleviating inflammatory injury in endothelial cells. Atherosclerosis 214:47\u201357","journal-title":"Atherosclerosis"},{"key":"1842_CR161","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.steroids.2004.02.004","volume":"69","author":"D Liu","year":"2004","unstructured":"Liu D, Dillon JS (2004) Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 69:279\u2013289","journal-title":"Steroids"},{"key":"1842_CR162","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.ATV.20.3.782","volume":"20","author":"T Hayashi","year":"2000","unstructured":"Hayashi T, Esaki T, Muto E, Kano H, Asai Y, Thakur NK, Sumi D, Jayachandran M, Iguchi A (2000) Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 20:782\u2013792","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1842_CR163","first-page":"224","volume":"101","author":"JA McCrohon","year":"2000","unstructured":"McCrohon JA, Death AK, Nakhla S, Jessup W, Handelsman DJ, Stanley KK, Celermajer DS (2000) Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis Circulation 101:224\u2013226","journal-title":"A sex difference with implications for atherogenesis Circulation"},{"key":"1842_CR164","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/jcem.84.6.5824","volume":"84","author":"GP Bernini","year":"1999","unstructured":"Bernini GP, Sgro\u2019 M, Moretti A, Argenio GF, Barlascini CO, Cristofani R, Salvetti A (1999) Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 84:2008\u20132012","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR165","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.7863\/jum.2007.26.9.1157","volume":"26","author":"EC Godia","year":"2007","unstructured":"Godia EC, Madhok R, Pittman J, Trocio S, Ramas R, Cabral D, Sacco RL, Rundek T (2007) Carotid artery distensibility: a reliability study. J Ultrasound Med 26:1157\u20131165","journal-title":"J Ultrasound Med"},{"key":"1842_CR166","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0895-7061(02)02966-7","volume":"15","author":"GM London","year":"2002","unstructured":"London GM, Cohn JN (2002) Prognostic application of arterial stiffness: task forces. Am J Hypertens 15:754\u2013758","journal-title":"Am J Hypertens"},{"key":"1842_CR167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.11.083","volume":"77","author":"C Palombo","year":"2016","unstructured":"Palombo C, Kozakova M (2016) Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications. Vasc Pharmacol 77:1\u20137","journal-title":"Vasc Pharmacol"},{"key":"1842_CR168","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/GME.0000000000000510","volume":"23","author":"C Shufelt","year":"2016","unstructured":"Shufelt C, Elboudwarej O, Johnson BD, Mehta P, Bittner V, Braunstein G, Berga S, Stanczyk F, Dwyer K, Merz CN (2016) Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study. Menopause 23:150\u2013157","journal-title":"Menopause"},{"key":"1842_CR169","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1507\/endocrj.K07E-130","volume":"55","author":"I Kanazawa","year":"2008","unstructured":"Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T (2008) Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus. Endocr J 55:667\u2013675","journal-title":"Endocr J"},{"key":"1842_CR170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","volume":"14","author":"GA Aguirre","year":"2016","unstructured":"Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I (2016) Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med 14:3","journal-title":"J Transl Med"},{"key":"1842_CR171","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/gme.0b013e31821f915b","volume":"18","author":"H Tagashira","year":"2011","unstructured":"Tagashira H, Bhuiyan S, Shioda N, Fukunaga K (2011) Distinct cardioprotective effects of 17\u03b2-estradiol and dehydroepiandrosterone on pressure overload-induced hypertrophy in ovariectomized female rats. Menopause 18:1317\u20131326","journal-title":"Menopause"},{"key":"1842_CR172","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/HYPERTENSIONAHA.108.114223","volume":"52","author":"MF Rossier","year":"2008","unstructured":"Rossier MF, Lenglet S, Vetterli L, Python M, Maturana A (2008) Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes. Hypertension 52:721\u2013728","journal-title":"Hypertension"},{"key":"1842_CR173","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cardiores.2005.05.009","volume":"67","author":"N Lalev\u00e9e","year":"2005","unstructured":"Lalev\u00e9e N, Rebsamen MC, Barr\u00e8re-Lemaire S, Perrier E, Nargeot J, B\u00e9nitah JP, Rossier MF (2005) Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res 67:216\u2013224","journal-title":"Cardiovasc Res"},{"key":"1842_CR174","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1210\/en.2012-1784","volume":"154","author":"T Mannic","year":"2013","unstructured":"Mannic T, Mouffok M, Python M, Yoshida T, Maturana AD, Vuilleumier N, Rossier MF (2013) DHEA prevents mineralo- and glucocorticoid receptor-induced chronotropic and hypertrophic actions in isolated rat cardiomyocytes. Endocrinology 154:1271\u20131281","journal-title":"Endocrinology"},{"key":"1842_CR175","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0008-6363(00)00017-1","volume":"46","author":"B Huang","year":"2000","unstructured":"Huang B, Qin D, Deng L, Boutjdir M, El Sherif N (2000) Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46:442\u2013449","journal-title":"Cardiovasc Res"},{"key":"1842_CR176","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/GME.0000000000000377","volume":"22","author":"GA Dunay","year":"2015","unstructured":"Dunay GA, Paragi P, S\u00e1ra L, \u00c1cs N, Bal\u00e1zs B, \u00c1goston V, R\u00e9p\u00e1s C, Ivanics T, Mikl\u00f3s Z (2015) Depressed calcium cycling contributes to lower ischemia tolerance in hearts of estrogen-deficient rats. Menopause 22:773\u2013782","journal-title":"Menopause"},{"key":"1842_CR177","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.HYP.26.6.1065","volume":"26","author":"M Barbagallo","year":"1995","unstructured":"Barbagallo M, Shan J, Pang PK, Resnick LM (1995) Effects of dehydroepiandrosterone sulfate on cellular calcium responsiveness and vascular contractility. Hypertension 26:1065\u20131069","journal-title":"Hypertension"},{"key":"1842_CR178","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.diabres.2018.10.002","volume":"146","author":"M Usman","year":"2018","unstructured":"Usman M, Gillies CL, Khunti K, Davies MJ (2018) Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: a systematic review and meta-analysis of randomised controlled trials. Diabetes Res Clin Pract 146:76\u201384","journal-title":"Diabetes Res Clin Pract"},{"key":"1842_CR179","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/diabetes.54.6.1816","volume":"54","author":"WD Strain","year":"2005","unstructured":"Strain WD, Chaturvedi N, Bulpitt CJ, Rajkumar C, Shore AC (2005) Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes 54:1816\u20131822","journal-title":"Diabetes"},{"key":"1842_CR180","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1161\/hc2501.091353","volume":"103","author":"M Roest","year":"2001","unstructured":"Roest M, Banga JD, Janssen WM, Grobbee DE, Sixma JJ, de Jong PE, de Zeeuw D, van Der Schouw YT (2001) Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103:3057\u20133061","journal-title":"Circulation"},{"key":"1842_CR181","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2337\/diacare.27.12.2893","volume":"27","author":"M Fukui","year":"2004","unstructured":"Fukui M, Kitagawa Y, Nakamura N, Kadono M, Hasegawa G, Yoshikawa T (2004) Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: a possible link between urinary albumin excretion and cardiovascular disease. Diabetes Care 27:2893\u20132897","journal-title":"Diabetes Care"},{"key":"1842_CR182","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.metabol.2007.04.011","volume":"56","author":"M Fukui","year":"2007","unstructured":"Fukui M, Ose H, Kitagawa Y, Yamazaki M, Hasegawa G, Yoshikawa T, Nakamura N (2007) Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus. Metabolism 56:1167\u20131173","journal-title":"Metabolism"},{"key":"1842_CR183","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.2337\/dc06-2325","volume":"30","author":"M Fukui","year":"2007","unstructured":"Fukui M, Ose H, Nakayama I, Hosoda H, Asano M, Kadono M, Mogami S, Hasegawa G, Yoshikawa T, Nakamura N (2007) Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentrations in women with type 2 diabetes. Diabetes Care 30:1886\u20131888","journal-title":"Diabetes Care"},{"key":"1842_CR184","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jth.13554","volume":"15","author":"LB Harrington","year":"2017","unstructured":"Harrington LB, Marck BT, Wiggins KL, McKnight B, Heckbert SR, Woods NF, LaCroix AZ, Blondon M, Psaty BM, Rosendaal FR et al (2017) Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women. J Thromb Haemost 15:80\u201390","journal-title":"J Thromb Haemost"},{"key":"1842_CR185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MED.0b013e3283461818","volume":"18","author":"RM Goel","year":"2011","unstructured":"Goel RM, Cappola AR (2011) Dehydroepiandrosterone sulfate and postmenopausal women. Curr Opin Endocrinol Diabetes Obes 18:171\u2013176","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1842_CR186","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2009.12.017","volume":"66","author":"M Panjari","year":"2010","unstructured":"Panjari M, Davis SR (2010) DHEA for postmenopausal women: a review of the evidence. Maturitas 66:172\u2013179","journal-title":"Maturitas"},{"key":"1842_CR187","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1210\/jc.2010-2888","volume":"96","author":"SR Davis","year":"2011","unstructured":"Davis SR, Panjari M, Stanczyk FZ (2011) Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 96:1642\u20131653","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR188","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1210\/jc.2014-2261","volume":"99","author":"T Elraiyah","year":"2014","unstructured":"Elraiyah T, Sonbol MB, Wang Z, Khairalseed T, Asi N, Undavalli C, Nabhan M, Altayar O, Prokop L, Montori VM et al (2014) Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab 99:3536\u20133542","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01842-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:30:39Z","timestamp":1605054639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":188,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01842-5","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"30 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}